Clinical Thought Leaders to Meet at Clinical Trials Congress 2004 to Define Industry Direction; Achieving Clinical Process Optimization to Maximizing Process Quality and Productivity
NEW YORK, Nov. 20, 2003--CTC 2004's (www.clinicalevent.com) unique 5-tracked program has over 60 Senior VP and Director level, clinical-decision makers. They will discuss varying perspectives on how to effectively maximize and measure ROI in clinical trials. The strong representation of top pharma and biotech companies included in the speaking faculty further supports the fact that CTC 2004 will be the leading event in the industry. Today and tomorrow's industry leaders dictated all five critical track topics for achieving clinical success; each track has been individually molded to address today's most pervasive issues, including: Patient Recruitment, Clinical Technologies, Clinical Study Design and Management, Global Clinical Trials; and Contracts, Budgets and Negotiations.
The unprecedented speaking faculty spearheading CTC 2004 is
composed of over 80% pharmaceutical and biotech industry
executives; including Pfizer, AstraZeneca, Eli Lilly, BMS,
Novartis, Wyeth, J&J, Aventis, Amgen, Genzyme, Imclone,
Schering, P&G and many more. CTC delivers more experience,
expertise and innovative strategies than any other conference
within the clinical trial arena. The array of panels discussions,
sessions, workshops and plenaries are all designed to deliver three
full days of strategic and pragmatic discussions that meet the
expectations for everyday job functionality. Highlighted conference
speakers include the most industry-respected individuals discussing
the paramount case studies that are shaping this industry,
including:
| -- | Sylva H. Collins, PhD, Vice President, Global EDC, NOVARTIS |
| -- | Christopher Gallen, PhD, Vice President and Chief of Clinical Operations, WYETH |
| -- | Ira Katz, MD, PhD, Vice President, Drug Evaluations, Clinical Operations, JOHNSON & JOHNSON |
| -- | Sanj Patel, Vice President, Clinical Research, GENZYME CORPORATION |
| -- | Michael Needle, MD, Vice President, Clinical Affairs, IMCLONE SYSTEMS |
CTC exposes the true barriers to efficient clinical trials by diving deeper into the important issues to uncover actual strategies for process optimization by offering the choice of 10 different controversial panel discussions.
CTC 2004 is endorsed by premier industry publications,
professional service organizations and by members of Big Pharma and
leading biotechnology companies. Delegates attending CTC will
include CEOs, Vice Presidents, Senior Vice Presidents, Directors
and Managers involved with all aspects of Clinical Operations,
Research, Project Management, Patient Recruitment, Business
Development, Regulatory Affairs, Data Management, Data Capture and
Information Technology. CTC 2004 is the only forum providing the
industry's leading experts a chance to discuss and exchange ideas,
resulting in essential information for the successful preparation,
execution and management of clinical trials. To download the
conference brochure and to register, please visit www.clinicalevent.com or call
212-661-3500.
About IIR
The Institute for International Research (IIR) is the world's leading knowledge and skills transfer company with a global network of 44 companies and 109 operating units. IIR works with more than 600,000 business executives annually, providing them with knowledge and skills through training, conferences, seminars, e-learning, blended solutions, publications, exhibitions, consulting and mentoring. Visit their Web site at www.iir-global.com.
For questions regarding media registration, please contact Maria
Palombini, mpalombini@iirusa.com or
212.661.3500 ext 3127.
CONTACT: Institute for International
Research
Maria Palombini, 212-661-3500 ext. 3127
mpalombini@iirusa.com
Posted: November 2003
